Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 07:51 am Sale |
2024-12-31 | 13G | Krystal Biotech, Inc. KRYS |
STATE STREET CORP STT |
1,278,975 4.400% |
-173,836 (-11.97%) |
Filing History |
| 2024-11-14 9:00 pm Sale |
2024-09-30 | 13G | Krystal Biotech, Inc. KRYS |
Redmile Group LLC | 810,245 2.800% |
-922,944 (-53.25%) |
Filing History |
| 2024-11-12 10:32 am Purchase |
2024-11-08 | 13G | Krystal Biotech, Inc. KRYS |
FMR CORP | 4,292,881 14.942% |
943,407 (+28.17%) |
Filing History |
| 2024-10-16 12:28 pm Purchase |
2024-09-30 | 13G | Krystal Biotech, Inc. KRYS |
STATE STREET CORP STT |
1,452,811 5.100% |
1,452,811 (New Position) |
Filing History |
| 2024-07-10 1:14 pm Purchase |
2024-06-28 | 13G | Krystal Biotech, Inc. KRYS |
The Vanguard Group | 2,869,136 10.050% |
433,362 (+17.79%) |
Filing History |
| 2024-07-08 4:32 pm Purchase |
2024-06-30 | 13G | Krystal Biotech, Inc. KRYS |
BLACKROCK INC BLK |
3,947,588 13.800% |
2,138,211 (+118.17%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Krystal Biotech, Inc. KRYS |
Redmile Group LLC | 1,733,189 6.100% |
-163,456 (-8.62%) |
Filing History |
| 2024-02-14 09:25 am Purchase |
2023-12-31 | 13G | Krystal Biotech, Inc. KRYS |
AVORO CAPITAL ADVISORS LLC | 2,565,555 9.100% |
1,155,555 (+81.95%) |
Filing History |
| 2024-02-13 5:08 pm Purchase |
2023-12-29 | 13G | Krystal Biotech, Inc. KRYS |
The Vanguard Group | 2,435,774 8.640% |
2,435,774 (New Position) |
Filing History |
| 2024-02-12 12:03 pm Purchase |
2024-02-09 | 13G | Krystal Biotech, Inc. KRYS |
FMR CORP | 3,349,474 11.874% |
963,576 (+40.39%) |
Filing History |
| 2024-02-09 09:16 am Sale |
2024-02-08 | 13G | Krystal Biotech, Inc. KRYS |
FMR CORP | 2,385,898 8.458% |
-227,374 (-8.70%) |
Filing History |
| 2024-01-29 3:26 pm Purchase |
2023-12-31 | 13G | Krystal Biotech, Inc. KRYS |
BLACKROCK INC BLK |
1,809,377 6.400% |
110,952 (+6.53%) |
Filing History |
| 2023-05-10 09:45 am Purchase |
2023-05-09 | 13G | Krystal Biotech, Inc. KRYS |
FMR CORP | 2,613,272 10.133% |
504,419 (+23.92%) |
Filing History |
| 2023-02-14 4:27 pm Purchase |
2022-12-31 | 13G | Krystal Biotech, Inc. KRYS |
Redmile Group LLC | 1,896,645 7.400% |
75,747 (+4.16%) |
Filing History |
| 2023-02-14 4:02 pm Sale |
2022-12-31 | 13G | Krystal Biotech, Inc. KRYS |
Point72 Asset Management, L.P. | 556,252 2.200% |
-1,304,418 (-70.10%) |
Filing History |
| 2023-02-14 09:33 am Purchase |
2022-12-31 | 13G | Krystal Biotech, Inc. KRYS |
AVORO CAPITAL ADVISORS LLC | 1,410,000 5.500% |
1,410,000 (New Position) |
Filing History |
| 2023-02-09 11:18 am Purchase |
2023-02-09 | 13G | Krystal Biotech, Inc. KRYS |
FMR CORP | 2,108,853 8.190% |
130,564 (+6.60%) |
Filing History |
| 2023-01-31 5:52 pm Purchase |
2022-12-31 | 13G | Krystal Biotech, Inc. KRYS |
BLACKROCK INC BLK |
1,698,425 6.600% |
92,929 (+5.79%) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Krystal Biotech, Inc. KRYS |
Redmile Group LLC | 1,820,898 7.300% |
145,862 (+8.71%) |
Filing History |
| 2022-02-14 4:49 pm Purchase |
2021-12-31 | 13G | Krystal Biotech, Inc. KRYS |
Point72 Asset Management, L.P. | 1,860,670 7.500% |
517,428 (+38.52%) |
Filing History |